losartan has been researched along with dinoprostone in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (32.35) | 18.2507 |
| 2000's | 15 (44.12) | 29.6817 |
| 2010's | 8 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Akabane, S; Imanishi, M; Kawamura, M; Kuramochi, M; Matsushima, Y; Omae, T | 1 |
| Chappell, MC; Diz, DI; Ferrario, CM; Jaiswal, N; Khosla, MC | 1 |
| Diz, DI; Ferrario, CM; Jaiswal, N; Khosla, MC; Tallant, EA | 1 |
| Ebihara, A; Fujimura, A; Sudoh, T | 1 |
| Catalioto, RM; Criscuoli, M; Giachetti, A; Porchia, R; Renzetti, AR; Subissi, A | 1 |
| Carey, RM; Siragy, HM | 2 |
| Carey, RM; Jaffa, AA; Margolius, HS; Siragy, HM | 1 |
| Burns, KD; Mangat, H; Peterson, LN | 1 |
| Carey, RM; Guerrant, RL; Jin, XH; Siragy, HM; Wang, ZQ | 1 |
| Bell-Quilley, C; Hilchey, S; Quilley, J | 1 |
| Sakata, Y; Wada, M; Watanabe, T | 1 |
| Arroyo, V; Bataller, R; Bosch, J; Garcia-Ramallo, E; Gasull, X; Ginès, P; Görbig, MN; Nicolás, JM; Rodés, J | 1 |
| Broulík, PD; Jirsa, M; Tesar, V; Zima, T | 1 |
| Cicha, MZ; Kopp, UC; Smith, LA | 4 |
| Johnson, RJ; Kang, DH; Mazzali, M; Ray, PE; Suga, S | 1 |
| Brännström, M; Matousek, M; Mikuni, M; Mitsube, K; Zackrisson, U | 1 |
| Cicha, MZ; Kopp, UC | 1 |
| Aihara, E; Hayashi, M; Kagawa, S; Takeuchi, K | 1 |
| Bulbena, O; Closa, D; Fernandez-Zabalegui, L; Marin-Arguedas, A; Molina-Molina, M; Mullol, J; Picado, C; Serrano-Mollar, A; Torrego, A; Xaubet, A | 1 |
| Caron, N; Flamion, B; Imig, JD; Joly, E; Kramp, R; Michel, A; Seqqat, R | 1 |
| Cicha, MZ; Kopp, UC; Yorek, MA | 1 |
| Carranza, A; Mayer, MA; Peredo, HA; Puyó, AM | 1 |
| Badzynska, B; Sadowski, J | 1 |
| Guo, C; Guo, RW; Liu, H; Qi, F; Wang, XM; Yang, LX; Ye, JS | 1 |
| Loke, WK; Ng, ET; Sim, MK | 1 |
| Boshra, V; El Wakeel, GA; Nader, MA | 1 |
| Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K | 1 |
| Loke, WK; Sethi, G; Sim, MK; Wang, H | 1 |
34 other study(ies) available for losartan and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Angiotensin II does not increase renal prostaglandin E2 in response to pressure reduction.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Dinoprostone; Dogs; Female; Imidazoles; Infusions, Intra-Arterial; Kidney; Losartan; Male; Renal Circulation; Renin; Saralasin; Tetrazoles | 1992 |
Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cells, Cultured; Dinoprostone; Endothelium, Vascular; Epoprostenol; Imidazoles; Losartan; Oligopeptides; Prostaglandins; Pyridines; Receptors, Angiotensin; Tetrazoles | 1992 |
The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cells, Cultured; Dinoprostone; Epoprostenol; Humans; Imidazoles; Losartan; Muscle, Smooth, Vascular; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured | 1991 |
Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Dinoprostone; Furosemide; Imidazoles; Indans; Losartan; Male; Prodrugs; Rats; Rats, Wistar; Tetrazoles | 1994 |
Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Cells, Cultured; Dinoprostone; DNA; Epoprostenol; Imidazoles; Inositol 1,4,5-Trisphosphate; Leucine; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Pyridines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Tetrazoles; Thiophenes; Thymidine | 1995 |
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Biphenyl Compounds; Cyclic AMP; Dinoprostone; Extracellular Space; Female; Imidazoles; Kidney; Kinetics; Losartan; Microdialysis; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Sodium, Dietary; Tetrazoles; Time Factors | 1996 |
Renin-angiotensin system modulates renal bradykinin production.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Bradykinin; Cyclic GMP; Dinoprostone; Dogs; Drug Combinations; Extracellular Space; Female; Hemodynamics; Imidazoles; Kidney; Losartan; Microdialysis; Oligopeptides; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1996 |
The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Diet, Sodium-Restricted; Dinoprost; Dinoprostone; Extracellular Space; Female; Homeostasis; Imidazoles; Kidney; Losartan; Microdialysis; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium, Dietary; Tetrazoles | 1997 |
Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors.
Topics: Angiotensin II; Animals; Blotting, Western; Calcium; Cyclooxygenase 1; Cyclooxygenase 2; Dihydrotachysterol; Dinoprostone; Fluorescent Antibody Technique; Hypercalcemia; Isoenzymes; Kidney; Kidney Cortex; Kidney Medulla; Losartan; Male; Membrane Proteins; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cyclic AMP; Cyclic GMP; Diet, Sodium-Restricted; Dinoprostone; Dose-Response Relationship, Drug; Guanethidine; Homeostasis; Imidazoles; Intestinal Absorption; Intestinal Mucosa; Jejunum; Kinetics; Losartan; Male; Mesenteric Arteries; Oligopeptides; Prazosin; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Water | 1998 |
Vascular and excretory effects of angiotensin II in the rat isolated perfused kidney: influence of an AT1 and a nonselective AT receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Female; Glomerular Filtration Rate; In Vitro Techniques; Kidney; Losartan; Male; Perfusion; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Urine; Vascular Resistance; Vasoconstrictor Agents | 1998 |
Angiotensin AT1 receptors in the preoptic area negatively modulate the cardiovascular and ACTH responses induced in rats by intrapreoptic injection of prostaglandin E2.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiovascular System; Dinoprostone; Injections; Losartan; Male; Oligopeptides; Preoptic Area; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2000 |
Angiotensin II induces contraction and proliferation of human hepatic stellate cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cell Division; Cell Size; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Humans; Imidazoles; Indomethacin; Iodine Radioisotopes; Liver; Losartan; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Penicillamine; Pyridines; Radioligand Assay; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium Nitrite; Thymidine; Vasoconstrictor Agents | 2000 |
Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Density; Dinoprost; Dinoprostone; Enalapril; F2-Isoprostanes; Female; Femur; Losartan; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Thromboxane B2 | 2001 |
Endogenous angiotensin modulates PGE(2)-mediated release of substance P from renal mechanosensory nerve fibers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dinoprostone; In Vitro Techniques; Kidney; Losartan; Male; Mechanoreceptors; Nerve Fibers; Neurons, Afferent; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sodium, Dietary; Substance P; Vasoconstrictor Agents | 2002 |
Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency.
Topics: Angiotensin Receptor Antagonists; Animals; Arginine; Chronic Disease; Dinoprostone; Kidney; Losartan; Male; Nitrates; Nitrites; Potassium Deficiency; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2002 |
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Heart Failure; Kidney; Losartan; Male; Models, Animal; Natriuresis; Neurons, Afferent; Pressure; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium; Sodium, Dietary; Substance P | 2003 |
Role of the angiotensin II system in regulation of ovulation and blood flow in the rat ovary.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Drug Synergism; Female; Imidazoles; Laser-Doppler Flowmetry; Losartan; Ovary; Ovulation; Plasminogen Activators; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2003 |
Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Kidney Pelvis; Losartan; Neurons, Afferent; Osmolar Concentration; Pertussis Toxin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P | 2004 |
ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Blood Pressure; Bradykinin; Dinoprostone; Duodenum; Enalapril; In Vitro Techniques; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction | 2005 |
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antimetabolites, Antineoplastic; Bleomycin; Cyclooxygenase 2; Dinoprostone; Losartan; Male; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE.
Topics: Adaptation, Physiological; Amidines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Dinoprostone; Hydroxyeicosatetraenoic Acids; Imidazoles; Indomethacin; Losartan; Male; Microcirculation; Nephrectomy; Norepinephrine; Pyridines; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Activation of endothelin-a receptors contributes to angiotensin-induced suppression of renal sensory nerve activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Endothelin A Receptor Antagonists; Kidney; Kidney Pelvis; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Peptides, Cyclic; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Substance P | 2007 |
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Baroreflex; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Kidney; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Substance P | 2008 |
Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Vessels; Dinoprostone; Drug Synergism; Epoprostenol; Fructose; Hemodynamics; In Vitro Techniques; Losartan; Male; Mesentery; Pioglitazone; PPAR gamma; Prostaglandins; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thromboxanes; Triglycerides | 2008 |
Opposed effects of prostaglandin E2 on perfusion of rat renal cortex and medulla: interactions with the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclooxygenase Inhibitors; Dinoprostone; Indomethacin; Infusions, Intra-Arterial; Kidney Cortex; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Male; Misoprostol; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Renal Artery; Renal Circulation; Renin-Angiotensin System; Ultrasonography; Vasoconstriction; Vasodilation | 2008 |
The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Basigin; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Imidazoles; Losartan; Macrophages; Nitrobenzenes; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction; Sulfonamides | 2010 |
Protective actions of des-aspartate-angiotensin I in mice model of CEES-induced lung intoxication.
Topics: Angiotensin I; Animals; Bronchoalveolar Lavage Fluid; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Intercellular Adhesion Molecule-1; Losartan; Lung; Male; Mice; Mice, Inbred BALB C; Mustard Gas; NADPH Oxidases; Peroxidase; Reactive Oxygen Species; Receptors, Immunologic; Signal Transduction | 2011 |
Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Kidney; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-2; Substance P; Sympathetic Nervous System | 2011 |
Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Interactions; Hypertension, Renovascular; Losartan; Male; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides | 2011 |
Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dinoprost; Dinoprostone; Disease Models, Animal; Group IV Phospholipases A2; Losartan; Male; Membrane Proteins; Mesenteric Artery, Superior; Phosphorylation; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Signal Transduction; Superoxides; Uridine Triphosphate; Vasoconstriction | 2011 |
Des-Aspartate-Angiotensin I Attenuates Mortality of Mice Exposed to Gamma Radiation via a Novel Mechanism of Action.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprostone; Female; Gamma Rays; Interleukin-6; Losartan; Mice; Mice, Inbred BALB C; Myelodysplastic Syndromes; Radiation-Protective Agents; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2015 |